| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390509 Compositions and methods for nutrition supplementation |
| 06/24/2008 | US7390508 Xenon is administered with an anesthetic selected from isoflurane, sevoflurane, and desflurane; treating hypoxic-ischemic (HI) insult |
| 06/24/2008 | US7390504 HDL-boosting combination therapy complexes |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/19/2008 | WO2008074001A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 06/19/2008 | WO2008073942A2 Pharmaceutical compositions and their methods of use |
| 06/19/2008 | WO2008073927A1 Ambrisentan combined with a renin inhibitor for hypertensive disorder |
| 06/19/2008 | WO2008072778A1 Therapeutic agent for urinary tract disease |
| 06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
| 06/19/2008 | WO2008072371A1 Preparation for sterilization or disinfection of tissue |
| 06/19/2008 | WO2008071790A2 Novel compositions and uses thereof |
| 06/19/2008 | WO2008071010A1 Combination treatments with selected growth/hormone regulatory factors for diabetes and related diseases |
| 06/19/2008 | WO2008055022A3 Carbamate compounds for use in treating depression |
| 06/19/2008 | WO2008024305A3 Bis (thiohydrazide amides) for treating melanoma |
| 06/19/2008 | WO2008022484A3 Combinations of 5-ht3 receptor antagonists for topical treatment of disorders of skin |
| 06/19/2008 | WO2008008507A3 Methods of treatment of diabetes |
| 06/19/2008 | WO2007131005A3 Use of organic compounds |
| 06/19/2008 | WO2007130627A3 Il-33 in the treatment and diagnosis of diseases and disorders |
| 06/19/2008 | WO2007130383A3 Compositions and treatments using pyridazine compounds and secretases |
| 06/19/2008 | WO2007121447A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 06/19/2008 | WO2007111866A3 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |
| 06/19/2008 | WO2006128674A8 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
| 06/19/2008 | US20080146679 Contacting the eye of a human in need with an effective amount of an electrokinetically altered oxygenated aqueous fluid ( saline solution, contact lens solution, storage, wetting or cleaning solultions) containing specific amount of oxygen; treats bacterial infection, dry eyes, allergical irritation |
| 06/19/2008 | US20080146662 Methods and compositions for treatment of cancer pain |
| 06/19/2008 | US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 06/19/2008 | US20080146603 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 06/19/2008 | US20080146598 Combinatorial drug therapy using polymer-drug conjugates |
| 06/19/2008 | US20080146584 Method of treating cancers using beta-lapachone or analogs or derivatives thereof |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146502 method for modulating the sensation of satiety perception and to agents useful for same. Such agents are useful in modulating, controlling or otherwise affecting inter alia obesity, anorexia, weight maintenance, metabolic energy levels and/or inflammatory conditions in a subject |
| 06/19/2008 | US20080146498 Diagnostic Agent For Ischemic Heart Disease Risk Group |
| 06/19/2008 | US20080146488 strongly immunogenic polypeptide to a more weakly immunogenic polypeptide can precipitate and focus a CpG adjuvant to increase in vivo priming of a cytotoxic T-lymphocyte (CTL) response, and thus increase the immunogenicity of the more weakly immunogenic polypeptide |
| 06/19/2008 | US20080146460 Optical probes and assays |
| 06/19/2008 | US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145859 Diagnosis and treatment of cancer |
| 06/19/2008 | US20080145404 Methods and compositions for regenerating connective tissue |
| 06/19/2008 | US20080145368 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | CA2673054A1 Novel compositions and uses thereof |
| 06/19/2008 | CA2672591A1 Treating agent of uropathy |
| 06/19/2008 | CA2672579A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 06/19/2008 | CA2671683A1 Pharmaceutical compositions and their methods of use |
| 06/19/2008 | CA2669535A1 Ambrisentan combined with a renin inhibitor for hypertensive disorders |
| 06/18/2008 | EP1932926A2 Method of diagnosing ovarian endometriosis |
| 06/18/2008 | EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 06/18/2008 | EP1932543A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 06/18/2008 | EP1932542A1 Antioxidant composition and its use in diabetes |
| 06/18/2008 | EP1932541A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 06/18/2008 | EP1932535A2 Stimulation of beta cell profileration |
| 06/18/2008 | EP1932529A1 Method of improved diuresis in individuals with impaired renal function |
| 06/18/2008 | EP1932524A1 Pharmaceutical preparations for treating inflammatory diseases |
| 06/18/2008 | EP1931425A1 Antituberculous composition comprising oxazole compounds |
| 06/18/2008 | EP1931386A2 Stabilized products, process and devices for preparing same |
| 06/18/2008 | EP1931375A2 Chemo-immunotherapy method |
| 06/18/2008 | EP1931343A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/18/2008 | EP1931322A1 Ikk inhibitors for the treatment of endometriosis |
| 06/18/2008 | EP1931205A2 Transglutaminase inhibitors and methods of use thereof |
| 06/18/2008 | EP1617849B1 Composition and uses of galectin antagonists |
| 06/18/2008 | EP1583542B1 Compositions and methods for combination antiviral therapy |
| 06/18/2008 | EP1496879A4 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 |
| 06/18/2008 | EP1418922B1 Use of negatively charched phospholipids for the preparation of a medicament for treatment and/or prevention of macular degeneration |
| 06/18/2008 | EP1259269B1 Agent for the treatment of wounds |
| 06/18/2008 | EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism |
| 06/18/2008 | CN101203251A 玻璃体可视化剂 Vitreous visualization agent |
| 06/18/2008 | CN101203244A Compositions of rennin inhibitor and insulin secernent or insulin sensitizer |
| 06/18/2008 | CN101203243A Remedy for xanthoma |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101203209A Topical ungual formulations |
| 06/18/2008 | CN101199855A Skinniness hormone packing matter water solution and application thereof |
| 06/18/2008 | CN101199850A Skin compound agent of oxide stress window period interference method |
| 06/18/2008 | CN101199849A Compound for medicine containing nucleoside (acid) and plant extract, preparing method and function thereof |
| 06/18/2008 | CN101199848A Drug compound for Ca channel retarder/diuretic/ folate coupling and function |
| 06/18/2008 | CN101199847A Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof |
| 06/18/2008 | CN101199593A Salvia miltiorrhiza valid component, preparing method and application |
| 06/18/2008 | CN101199519A Combination containing clacillin or derivative and preparing method thereof |
| 06/18/2008 | CN101199480A Compounded propofol fat emulsion injection containing analgesics and process for preparing same |
| 06/18/2008 | CN100394982C Inflammation-resistant modified imvite and preparing method thereof |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388075 Medicament containing activated antithrombin III |
| 06/17/2008 | US7387994 Antitumor, anticancer agents; particles or coils or stents coated solid-phase agent comprising a binding agent comprising collagen are directed to target vasculature, such as the vasculature of solid tumor masses or aneurysms |
| 06/17/2008 | US7387894 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 06/17/2008 | US7387879 Diagnosis of tauopathies |
| 06/17/2008 | US7387799 Mixture of catalytic metal compound, coenzyme, reducing agents or oxidizer and adjuvant; applying as aerosol, or film to medical equipment, filters, air conditioner |
| 06/17/2008 | US7387792 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387789 Transdermal delivery of non-steroidal anti-inflammatory drugs |
| 06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |